Literature DB >> 11800296

Invasive pneumococcal infection and drug-resistant Streptococcus pneumoniae in Thai children.

C Pancharoen1, A Chongthaleong, S Reinprayoon, U Thisyakorn.   

Abstract

Sixty-eight children with systemic Streptococcus pneumoniae infection were identified by hospital chart review between 1986-1997. The age distribution varied from 2 days to 15 years, with a mean age of 3.3 years. There were 35 boys and 33 girls. Four clinical entities included 30 cases of meningitis, 20 cases of pneumonia, 10 cases of peritonitis and 8 cases of septicemia/bacteremia. Forty patients (58.8%) had underlying diseases. Seventeen patients (25.0%) developed early complications and the mortality rate was 8.8 per cent. The percentage of susceptible isolates to penicillin, chloramphenicol, cefotaxime/ceftriaxone, ciprofloxacin, imipenem and vancomycin were 69.6, 91.3, 100.0, 87.2, 100.0 and 97.1 per cent, respectively. There were six cases of drug-resistant S. pneumoniae (DRSP) infection; 3 cases of meningitis, one case of pneumonia, one case of infective endocarditis and one case of purpura fulminans. Our data indicate that S. pneumoniae infection is relatively serious and life-threatening. There is a trend of increasing prevalence of invasive pneumococcal and DRSP infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800296

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Serotypes and Vaccine Coverage of Streptococcus Pneumoniae Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai.

Authors:  Anchalee Wangirapan; Satja Issaranggoon Na Ayuthaya; Wasan Katip; Nongyao Kasatpibal; Raktham Mektrirat; Usanee Anukool; Peninnah Oberdorfer
Journal:  Pathogens       Date:  2020-11-26

2.  Systematic review of the clinical outcomes of pneumonia with a penicillin-group resistant pneumococcus in respiratory and blood culture specimens in children in low- and middle-income countries.

Authors:  Maeve Hume-Nixon; Ruth Lim; Fiona Russell; Hamish Graham; Claire von Mollendorf; Kim Mulholland; Amanda Gwee
Journal:  J Glob Health       Date:  2022-08-22       Impact factor: 7.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.